Slingshot Biosciences is a biotech company focused on synthetic cell development. Synthetic cells can have a huge impact—improve the accuracy of biomedical instruments, lower the cost of drug development and diagnostics, and make healthcare more accessible around the world. We’ve raised a Series A round and the company is still small enough to know everyone.